method for differential correction of endothelial dysfunction in patients renoparenchymatous arterial hypertension

摘要

A method for differential correction of endothelial dysfunction in patients renoparenchymatous arterial hypertension comprising administering of fosinopril angiotensin-converting enzyme inhibitor on the background of conventional therapies. Fosinopril is administered depending on the level of concentration of endothelin- serum, which is determined quantitatively by radioimmunoassay.